Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.

Cancer treatment and research

Volumn 108, Issue , 2001, Pages 257-265

  Venugopal, P ^a   Manson, S ^a   Preisler, H D ^a  

^a RUSH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE;

ACUTE DISEASE; ADULT; AGE; AGED; BLOOD COMPONENT THERAPY; CASE MANAGEMENT; DISEASE FREE SURVIVAL; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PALLIATIVE THERAPY; RECURRENT DISEASE; REMISSION; REVIEW; SECOND CANCER;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD COMPONENT TRANSFUSION; CANCER VACCINES; CASE MANAGEMENT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG DELIVERY SYSTEMS; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; PALLIATIVE CARE; RECURRENCE; REMISSION INDUCTION;

MLCS; MLOWN;

EID: 0035238416     PISSN: 09273042     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-1463-3_13     Document Type: Review

References (15)